Zum Inhalt springen
Department of Biology
Home
About
What is Lymphoma?
The Challenge
Steering Committee
Call for Projects
Research
Home
About
What is Lymphoma?
The Challenge
Steering Committee
Call for Projects
Research
Department
of Biology
Home
About
What is Lymphoma?
The Challenge
Steering Committee
Call for Projects
Research
Home
About
What is Lymphoma?
The Challenge
Steering Committee
Call for Projects
Research
Supported Projects
21–03
Overcoming the challenge of T-cell lymphoma treatment by safe and efficacious anti-CD30 radioimmunotherapy with β-particle and ultra-short range Auger and conversion electron emitting radionuclides
Prof. Dr. Roger Schibli
ETH Zurich
Prof. Dr. med. Urban Novak
Inselspital / University Hospital Bern
é
21–01
Effector-target cell interactions in engineered immune-therapy against hematologic malignancies
Prof. Dr. Timm Schroeder
ETH Zurich
Prof. Dr. med. Markus G. Manz
University Hospital Zurich
é
21–02
Understanding how clonal hematopoiesis feeds lymphoma
Prof. Dr. med. Andrea Alimonti
ETH Zurich
Prof. Dr. med. Emanuele Zucca
Ente Ospedaliero Cantonale (EOC) / Oncology Institute of Southern Switzerland (IOSI)
é
22–01
Exploring the potential of targeting IL-21/IL-21R signaling to eliminate human acute myeloid leukemia stem cells
Prof. Dr. Manfred Kopf
ETH Zurich
Prof. Dr. Carsten Riether
Inselspital & University of Bern
é
22–02
Regulatory T-cells as tumor-promoting cellular partners and potential therapeutic targets in diffuse large B-cell lymphoma
Prof. Dr. Nicola Aceto
ETH Zurich
Prof. Dr. Alexandar Tzankov
University Hospital Basel
é
23–01
Harnessing gut microbiome metabolism for personalized treatment of lymphoma and leukemia
Prof. Dr. Nicholas Bokulich
ETH Zurich
Prof. Dr. med. Jörg Halter
University Hospital Basel
é
25–01
Targeting Metabolic Dependencies in MPN HSPCs
Prof. Dr. Nina Cabezas Wallscheid
ETH Zürich
Prof. Dr. Alexandre Theocharides
UZH
é
24–01
Hematopoietic Stem and Progenitor Cell-State–Cell-Fate Trajectories during the Development of TP53-mutant Leukemia
Prof. Dr. Niko Beerenwinkel
ETH Zürich
Prof. Dr. Steffen Boettcher
University Hospital Zurich
é
24–02
24 – 02
Prof. Dr. Andreas Moor
ETH Zürich
Prof. Dr. med. Thorsten Zenz
Universitätsspital Zürich
é
25–01
Targeting Metabolic Dependencies in MPN HSPCs
Prof. Dr. Nina Cabezas Wallscheid
ETH Zürich
Prof. Dr. Alexandre Theocharides
UZH
é
24–01
Hematopoietic Stem and Progenitor Cell-State–Cell-Fate Trajectories during the Development of TP53-mutant Leukemia
Prof. Dr. Niko Beerenwinkel
ETH Zürich
Prof. Dr. Steffen Boettcher
University Hospital Zurich
é
24–02
24 – 02
Prof. Dr. Andreas Moor
ETH Zürich
Prof. Dr. med. Thorsten Zenz
Universitätsspital Zürich
é
